Laminin 511蛋白,Laminin 511
  • Laminin 511蛋白,Laminin 511
  • Laminin 511蛋白,Laminin 511
  • Laminin 511蛋白,Laminin 511

Laminin 511蛋白-ACROBiosystems百普赛斯

价格 询价
包装 200ug 500ug 1000ug
最小起订量 200ug
发货地 北京
更新日期 2024-08-09
微信洽谈

产品详情

中文名称:Laminin 511蛋白英文名称:Laminin 511
品牌: 百普赛斯产地: 北京
保存条件: -20°C to -70°C纯度规格: 99.9%
产品类别: 重组蛋白
货号: Laminin 511用途范围: 药物开发等
规格: 100ug是否进口:
2024-08-09 Laminin 511蛋白 Laminin 511 200ug/RMB;500ug/RMB;1000ug/RMB 百普赛斯 北京 -20°C to -70°C 99.9% 重组蛋白

laminin.jpg

Human Laminin 511 Protein, premium grade

产品描述(Product Details

Laminin 511 E8 (LN511-E8) is a recombinant human protein that provides a defined surface for in vitro feeder-free culture of multiple human pluripotent stem cells (PSCs). Being a truncated form of laminin 511, LN511-E8 serves as a functionally minimal form that retain the full capability for binding to integrins. LN511-E8 has been proven to maintain normal growth characteristics and stemness in multiple PSC lines without simultaneous differentiation, which includes ESC, iPSC, MSC etc. In addition, LN511-E8 has been demonstrated to support PSC growth for >10 passages without any signs of karyotypic abnormalities and to maintain the ability of PSCs to differentiate into all three germ line lineages. As published by Takamichi Miyazaki et al. , the LN511-E8 variant of laminin 511 shows higher efficiency for supporting the adhesion of dissociated cells than did wild-type laminin 511 which makes a cost-effective choice.

Optimized and defined surface

Laminin 511 E8 (LN511-E8) has been proved to allow single-cell seeding at low density. In a feeder-free culture system, the seeded cells demonstrate high motility with higher clonal survival.

Physiology-related

The laminin 511 isoform is crucial to the growth and maintenance of hPSCs in human through its binding to cell receptors a6B1 integrin. LN511-E8 is truncated laminin 511 isoform which works in multiple stem cell lines, from iPSC to hESC and MSC.

Better Adhesion

LN511-E8 variant of laminin 511 shows higher efficiency for supporting the adhesion of dissociated cells than did wild-type laminin 511.

Cost Effective

LN511-E8 maintains pluripotency at a lower dose without simultaneous differentiation when compared to laminin 521. Hence LN511-E8 provides a cost-effective option for feeder free culture of human pluripotent stem cells (PSCs).

Reduce Variability 

LN511-E8 is a defined, recombinant human protein with better lot-to-lot consistency that reduces variability in your PSC cultures.

产品参数(Key parameter

2.jpg

重构方法(Reconstitution

Please see Certificate of Analysis for specific instructions.

For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

制剂(Formulation

Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

Contact us for customized product form or formulation.

存储(Storage

For long term storage, the product should be stored at lyophilized state at -20°C or lower.

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:

1. -20°C to -70°C for 24 months in lyophilized state;

2. -70°C for 3 months under sterile conditions after reconstitution.

3.jpg

Laminin 511分子背景

Laminin 511 E8 is a truncated laminin 511, which is one of the ECM proteins. laminin E8s serve as functionally minimal forms that retain the full capability for binding to integrins. Laminin 511-E8 consists of the C-terminal end of the alpha 5, beta 1, and gamma 1 chains. The laminin-511 heterotrimer (α5β1γ1) is one of the isoforms to be identified and a potent adhesive and pro-migratory substrate for a variety of normal and tumor cell lines in vitro. Previous studies indicated that laminin-511 contributes to tumor dissemination and metastasis in advanced breast carcinomas and other tumor types. Additionally, latest research uncovered that Laminin 511 might be a target antigen and involved in autoimmune pancreatitis.

Laminin 511用户评价

4.jpg


关键字: Laminin 511;Laminin蛋白;层粘连蛋白;Laminin;Laminin 521;

公司简介

百普赛斯集团ACROBiosystems Group(股票代码:301080)是成立于2010年的跨国生物科技公司,是为全球生物医药、健康产业领域提供关键生物试剂产品及解决方案的行业平台型基石企业。2021年在创业板上市。百普赛斯集团业务遍布全球,横跨亚洲、北美洲、欧洲,在中国、美国、瑞士等12个城市设有办公室、研发中心及生产基地。目前累计服务客户超6000家,与全球Top 20医药企业均建立了长期、稳定的合作伙伴关系。集团旗下拥有品牌ACROBiosystems百普赛斯、bioSeedin柏思荟、Condense Capital垦拓资本和ACRODiagnostics百斯医学等。
成立日期 2010-07-22 (15年) 注册资本 8000万人民币
员工人数 500人以上 年营业额 ¥ 1亿以上
主营行业 医药中间体,原料药,激素类,氨基糖苷类,中枢神经系统用药 经营模式 工厂,试剂
  • 北京百普赛斯生物科技股份有限公司
VIP 1年
  • 公司成立:15年
  • 注册资本:8000万人民币
  • 企业类型:其他股份有限公司(上市)
  • 主营产品:重组蛋白,抗原,抗体,试剂盒
  • 公司地址:北京市北京经济技术开发区宏达北路8号4幢4层
询盘
内容声明:
以上所展示的信息由商家自行提供,内容的真实性、准确性和合法性由发布商家负责。 商家发布价格指该商品的参考价格,并非原价,该价格可能随着市场变化,或是由于您购买数量不同或所选规格不同而发生变化。最终成交价格,请咨询商家,以实际成交价格为准。请意识到互联网交易中的风险是客观存在的
主页 | 企业会员服务 | 广告业务 | 联系我们 | 旧版入口 | 中文MSDS | CAS Index | 常用化学品CAS列表 | 化工产品目录 | 新产品列表 |投诉中心
Copyright © 2008 ChemicalBook 京ICP备07040585号  京公海网安备110108000080号  All rights reserved.
400-158-6606